?one prior regimen of chemotherapy for Innovative breast most cancers and over the full demo, earlier exposure to any FGFR inhibitor, main surgical procedures or radiotherapy inside 4 weeks before 1st dose of review procedure and having strong inhibitors or inducers of CYP3A4 or CYP2D6. Any of the subsequent cardiac requirements precluded sufferers